Total Payments
$2,524
2024 Payments
$277.98
Companies
29
Transactions
101
Medicare Patients
2,437
Medicare Billing
$330,941
Payment Breakdown by Category
Food & Beverage$2,410 (95.5%)
Education$113.88 (4.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,410 | 97 | 95.5% |
| Education | $113.88 | 4 | 4.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $439.89 | 19 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $249.80 | 14 | $0 (2019) |
| PROCEPT BioRobotics Corporation | $200.60 | 2 | $0 (2022) |
| Janssen Biotech, Inc. | $188.51 | 6 | $0 (2024) |
| PFIZER INC. | $181.90 | 9 | $0 (2024) |
| Incyte Corporation | $144.25 | 8 | $0 (2019) |
| Boston Scientific Corporation | $123.32 | 3 | $0 (2023) |
| Laborie Medical Technologies Corp. | $107.60 | 1 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $102.99 | 5 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $76.47 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $277.98 | 7 | Laborie Medical Technologies Corp. ($107.60) |
| 2023 | $227.34 | 7 | Boston Scientific Corporation ($100.10) |
| 2022 | $403.23 | 11 | PROCEPT BioRobotics Corporation ($200.60) |
| 2021 | $194.37 | 9 | Astellas Pharma US Inc ($100.59) |
| 2020 | $203.55 | 9 | Merck Sharp & Dohme Corporation ($44.80) |
| 2019 | $351.67 | 17 | Astellas Pharma US Inc ($46.77) |
| 2018 | $361.59 | 19 | Janssen Biotech, Inc. ($88.56) |
| 2017 | $504.09 | 22 | E.R. Squibb & Sons, L.L.C. ($191.48) |
All Payment Transactions
101 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $29.17 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: Oncology | ||||||
| 06/26/2024 | Astellas Pharma Global Development | Xtandi (Drug) | Food and Beverage | In-kind items and services | $37.48 | General |
| Category: Oncology | ||||||
| 05/22/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 05/16/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $107.60 | General |
| Category: Urology | ||||||
| 04/24/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: ONCOLOGY | ||||||
| 02/28/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $33.31 | General |
| Category: Oncology | ||||||
| 12/29/2023 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: UROTHELIAL CANCER | ||||||
| 11/22/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: General - Male SUI_URO | ||||||
| 08/23/2023 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $31.80 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/26/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Urology | ||||||
| 05/04/2023 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $80.10 | General |
| Category: LithoVue_URO | ||||||
| 01/25/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Oncology | ||||||
| 11/23/2022 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: ONCOLOGY | ||||||
| 09/28/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Oncology | ||||||
| 08/24/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/27/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Urology | ||||||
| 07/13/2022 | PROCEPT BioRobotics Corporation | AQUABEAM ROBOTIC SYSTEM (Device) | Food and Beverage | In-kind items and services | $37.43 | General |
| Category: Urology | ||||||
| 06/22/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Oncology | ||||||
| 05/01/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Oncology | ||||||
| 04/27/2022 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: ONCOLOGY | ||||||
| 04/08/2022 | PROCEPT BioRobotics Corporation | AQUABEAM ROBOTIC SYSTEM (Device) | Food and Beverage | In-kind items and services | $163.17 | General |
| Category: Urology | ||||||
| 03/23/2022 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Oncology | ||||||
| 02/23/2022 | Bayer HealthCare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $20.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 554 | 745 | $239,356 | $67,219 |
| 2022 | 11 | 551 | 772 | $293,956 | $72,698 |
| 2021 | 13 | 672 | 937 | $342,138 | $97,828 |
| 2020 | 13 | 660 | 942 | $333,630 | $93,197 |
Total Patients
2,437
Total Services
3,396
Medicare Billing
$330,941
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 122 | 157 | $96,555 | $28,896 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 129 | 170 | $53,210 | $14,682 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 128 | 152 | $32,072 | $9,270 | 28.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 56 | 56 | $25,480 | $6,025 | 23.6% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 19 | 19 | $12,730 | $3,450 | 27.1% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 22 | 24 | $8,952 | $2,752 | 30.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $6,405 | $1,525 | 23.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 23 | 30 | $2,010 | $347.70 | 17.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 11 | 12 | $780.00 | $230.40 | 29.5% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 23 | 104 | $1,162 | $42.36 | 3.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 116 | 146 | $88,447 | $26,253 | 29.7% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 12 | 102 | $85,857 | $14,209 | 16.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 140 | 159 | $33,549 | $9,121 | 27.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 88 | 99 | $30,987 | $8,832 | 28.5% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2022 | 13 | 13 | $27,976 | $7,706 | 27.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 27 | 27 | $12,275 | $3,167 | 25.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 30 | 30 | $9,102 | $2,323 | 25.5% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 12 | 17 | $1,529 | $478.76 | 31.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 91 | 114 | $2,052 | $338.82 | 16.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 21 | $1,407 | $250.47 | 17.8% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 11 | 44 | $774.40 | $17.38 | 2.2% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 169 | 204 | $109,344 | $37,363 | 34.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2021 | 16 | 162 | $109,274 | $23,703 | 21.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 132 | 157 | $33,127 | $9,682 | 29.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 77 | 95 | $29,735 | $8,675 | 29.2% |
About Dr. Simon Mcrae, MD
Dr. Simon Mcrae, MD is a Urology healthcare provider based in Worcester, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992774723.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Simon Mcrae, MD has received a total of $2,524 in payments from pharmaceutical and medical device companies, with $277.98 received in 2024. These payments were reported across 101 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($2,410).
As a Medicare-enrolled provider, Mcrae has provided services to 2,437 Medicare beneficiaries, totaling 3,396 services with total Medicare billing of $330,941. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Worcester, MA
- Active Since 03/15/2006
- Last Updated 02/18/2009
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1992774723
Products in Payments
- XTANDI (Drug) $386.62
- AQUABEAM ROBOTIC SYSTEM (Device) $200.60
- OPDIVO (Biological) $188.17
- JAKAFI (Drug) $144.25
- Xtandi (Drug) $139.32
- Erleada (Drug) $126.95
- Optilume BPH Drug Coated Balloon Catheter (Device) $107.60
- LithoVue (Device) $80.10
- JELMYTO (Drug) $75.14
- GILOTRIF (Drug) $70.17
- Myrbetriq (Drug) $63.34
- EMPLICITI (Biological) $61.63
- ERLEADA (Drug) $61.56
- SPRYCEL (Drug) $59.19
- Xofigo (Drug) $57.99
- LUPRON DEPOT (Drug) $54.74
- XIAFLEX (Biological) $52.98
- TECENTRIQ (Biological) $47.99
- LYNPARZA (Drug) $34.93
- ELIGARD (Drug) $29.17
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Worcester
Mr. George Haleblian, M.d, M.D
Urology — Payments: $73,837
Urology $73,837
Rachel Engelberg, M.d, M.D
Urology — Payments: $59,859
Urology $59,859
Matthew Chabot
Urology — Payments: $50,385
Urology $50,385
Dr. Bhalchandra Parulkar, Md, Mch, MD, MCH
Urology — Payments: $39,700
Urology $39,700
Chintan Patel, M.d, M.D
Urology — Payments: $27,827
Urology $27,827
Dr. Brett Carswell, Md, MD
Urology — Payments: $5,517
Urology $5,517